Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1) Stock Forecast & Price Target
5HZ1 Analyst Ratings
Moderate Buy
2Buy2Hold0Sell
Based on 4 analysts giving stock ratings to Hangzhou Tigermed Consulting Co., Ltd. Class H in the past 3 months
5HZ1 Stock 12 Month Forecast
Average Price Target
EUR 5.42â–˛(27.89% Upside)Based on 4 Wall Street analysts offering 12 month price targets for Hangzhou Tigermed Consulting Co., Ltd. Class H in the last 3 months. The average price target is EUR 5.42 with a high forecast of EUR 5.98 and a low forecast of EUR 4.66. The average price target represents a 27.89% change from the last price of EUR 4.24.
Past 12 Months12 Month ForecastDec2025Sep2026
HighEUR 5.98
AverageEUR 5.42
LowEUR 4.66
Highest Price TargetHighestEUR 5.98Average Price TargetEUR 5.42Lowest Price TargetLowestEUR 4.66
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | UBS | EUR 5.80→EUR 5.98 | buy | 41.10%Upside | Reiterated | 10/29/26 | ||
| David Shang | Jefferies | EUR 5.12 | hold | 20.71%Upside | Downgraded | 09/02/26 | ||
| Chris Pan | Goldman Sachs | EUR 5.93 | buy | 39.76%Upside | Reiterated | 08/30/26 | ||
| Unknown AnalystNot Ranked | J.P. Morgan | EUR 4.66 | hold | 9.98%Upside | Reiterated | 08/03/26 | ||
| Unknown AnalystNot Ranked | Citi | EUR 8.30 | buy | 95.82%Upside | Reiterated | 07/21/26 | ||
| Unknown AnalystNot Ranked | Bank of China | EUR 5.46 | buy | 28.76%Upside | Reiterated | 05/02/26 | ||
| Unknown AnalystNot Ranked | CLSA | EUR 6.38 | buy | 50.49%Upside | Reiterated | 04/28/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | EUR 6.37 | buy | 50.22%Upside | Reiterated | 04/21/26 | ||
| Unknown AnalystNot Ranked | Bank of America Securities | EUR 5.69 | buy | 34.12%Upside | Reiterated | 03/31/26 | ||
| Linda Shu | HSBC | EUR 5.81→EUR 6.14 | buy | 44.85%Upside | Reiterated | 11/05/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Unknown AnalystNot Ranked | 10/29/26 | EUR 5.80→EUR 5.98 | buy | 41.10%Upside | Reiterated | UBS | ||
| David Shang | 09/02/26 | EUR 5.12 | hold | 20.71%Upside | Downgraded | Jefferies | ||
| Chris Pan | 08/30/26 | EUR 5.93 | buy | 39.76%Upside | Reiterated | Goldman Sachs | ||
| Unknown AnalystNot Ranked | 08/03/26 | EUR 4.66 | hold | 9.98%Upside | Reiterated | J.P. Morgan | ||
| Unknown AnalystNot Ranked | 07/21/26 | EUR 8.30 | buy | 95.82%Upside | Reiterated | Citi | ||
| Unknown AnalystNot Ranked | 05/02/26 | EUR 5.46 | buy | 28.76%Upside | Reiterated | Bank of China | ||
| Unknown AnalystNot Ranked | 04/28/26 | EUR 6.38 | buy | 50.49%Upside | Reiterated | CLSA | ||
| Unknown AnalystNot Ranked | 04/21/26 | EUR 6.37 | buy | 50.22%Upside | Reiterated | Citic Securities | ||
| Unknown AnalystNot Ranked | 03/31/26 | EUR 5.69 | buy | 34.12%Upside | Reiterated | Bank of America Securities | ||
| Linda Shu | 11/05/25 | EUR 5.81→EUR 6.14 | buy | 44.85%Upside | Reiterated | HSBC |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Hangzhou Tigermed Consulting Co., Ltd. Class H
3 Months
Success Rate3/4 ratings generated profit
75%
Average Return
+10.38%
Copying Chris Pan's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +10.38% per trade.
1 Year
Success Rate3/4 ratings generated profit
75%
Average Return
+1.27%
Copying Chris Pan's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +1.27% per trade.
2 Years
Success Rate2/4 ratings generated profit
50%
Average Return
-1.43%
Copying Chris Pan's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -1.43% per trade.
5HZ1 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 1 | 1 | 0 |
| Buy | 4 | 1 | 2 | 2 | 3 |
| Hold | 0 | 0 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 5 | 3 | 4 | 5 | 5 |
In the current month, 5HZ1 has received 3 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 5HZ1 average Analyst price target in the past 3 months is 5.42.
5HZ1 Financial Forecast
HighEUR 0.07
ConsensusEUR 0.06
LowEUR 0.06
5HZ1 Earnings Forecast
Next quarter’s earnings estimate for 5HZ1 is EUR 0.06 with a range of EUR 0.06 to EUR 0.07. The previous quarter’s EPS was EUR 0.02. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 272M
ConsensusEUR 272M
LowEUR 272M
5HZ1 Sales Forecast
Next quarter’s sales forecast for 5HZ1 is EUR 272.40M with a range of EUR 272.40M to EUR 272.40M. The previous quarter’s sales results were EUR 276.77M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
5HZ1 Stock Forecast FAQ
What is DE:5HZ1’s average 12-month price target, according to analysts?
Based on analyst ratings, Hangzhou Tigermed Consulting Co., Ltd. Class H’s 12-month average price target is €5.42.
What is DE:5HZ1’s upside potential, based on the analysts’ average price target?
Hangzhou Tigermed Consulting Co., Ltd. Class H has 27.89% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hangzhou Tigermed Consulting Co., Ltd. Class H a Buy, Sell or Hold?
Hangzhou Tigermed Consulting Co., Ltd. Class H has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 2 hold ratings and 0 sell ratings.
What is Hangzhou Tigermed Consulting Co., Ltd. Class H’s share price target?
The average share price target for Hangzhou Tigermed Consulting Co., Ltd. Class H is €5.42. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €5.98, and the lowest forecast is €4.66. The average share price target represents a 27.89% increase from the current price of €4.24.
What do analysts say about Hangzhou Tigermed Consulting Co., Ltd. Class H?
Hangzhou Tigermed Consulting Co., Ltd. Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Hangzhou Tigermed Consulting Co., Ltd. Class H?
To buy shares of DE:5HZ1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
